ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrea A Howard, MD
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Addis Ketema Health Center
Dire Dawa, Ethiopia
- Dire Dawa Health Center
Dire Dawa, Ethiopia
- Gende Gerada Health Center
Dire Dawa, Ethiopia
- Gende Kore Health Center
Dire Dawa, Ethiopia
- Goro Health Center
Dire Dawa, Ethiopia
- Legehare Health Center
Dire Dawa, Ethiopia
- Melka-Jebdu Health Center
Dire Dawa, Ethiopia
- Sabian Health Center
Dire Dawa, Ethiopia
- Arategna Health Center
Harar, Ethiopia
- Jinela Health Center
Harar, Ethiopia
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2013
- Primary completion
- 29 Feb 2016
- Completion
- 7 May 2021
- Last update posted
- 13 Jul 2021
- Registered enrollment
- 338
- Registry id
- NCT01926379
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.